T. Rothmann et al., REPLICATION OF ONYX-015, A POTENTIAL ANTICANCER ADENOVIRUS, IS INDEPENDENT OF P53 STATUS IN TUMOR-CELLS, Journal of virology (Print), 72(12), 1998, pp. 9470-9478
The 55-kDa E1B protein of adenovirus, which binds to and inactivates t
he tumor suppressor protein p53, is not expressed in the adenoviral mu
tant termed ONYX-015 (i.e., dl1520). It was reported that the mutant v
irus due to a deletion in E1B is able to replicate only in cells defic
ient for wild-type p53, Accordingly, dl1520 is currently being evaluat
ed as a potential tool in the therapy of p53 deficient cancers. In con
trast, we report here that dl1520 replicates independently of the p53
status in various tumor cell lines (U87, RKO, A549, H1299, and U373),
In addition, the inhibition of p53-mediated transcriptional activation
in wild-type p53 containing U2OS cells, by overexpression bf a transd
ominant negative p53 mutant, did not render the cells permissive for d
l1520 replication. Finally, we show that, depending on the multiplicit
y of infection, the deleted virus is able to replicate in and to kill
primary human cells. Thus, the molecular basis for the growth differen
ces of dl1520 within different cell types remains to be determined.